Stock 301206 SHANDONG SANYUAN BIOTECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Shandong Sanyuan Biotechnology Co.,Ltd.

Equities

301206

CNE100005774

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-05-26 EDT 		5-day change 1st Jan Change
28.69 CNY +1.56% Intraday chart for Shandong Sanyuan Biotechnology Co.,Ltd. -1.51% -0.66%
04-22 Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-10 Certain A Shares of Shandong Sanyuan Biotechnology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024. CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Shandong Sanyuan Biotechnology Co.,Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 29 May 2024
CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Certain A Shares of Shandong Sanyuan Biotechnology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024.
CI
EU Opens Anti-Dumping Probe Into Sanyuan Biotechnology’s Erythritol Products
MT
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shandong Sanyuan Biotechnology Co.,Ltd.(XSEC:301206) added to S&P Global BMI Index
CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Shandong Sanyuan Biotechnology Co.,Ltd. Implements Final Profit Distribution Plan (A Shares) for 2022, Payable on 21 June 2023
CI
Shandong Sanyuan Biotechnology Co.,Ltd. Approves Cash Dividend for the Year 2022
CI
Shandong Sanyuan Biotechnology Co.,Ltd. Proposal Final Cash Dividend for 2022
CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Hapioneer announced that it has received $8.200000 million in funding from Shandong Sanyuan Biotechnology Co.,Ltd. and other investors.
CI
Shandong Peixue Bioengineering Co., Ltd. announced that it expects to receive CNY 60 million in funding from Shandong Sanyuan Biotechnology Co.,Ltd.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 301206 Stock
  4. News Shandong Sanyuan Biotechnology Co.,Ltd.